FitLife is betting the company on Irwin Naturals: execute the Amazon margin-arbitrage playbook, de-lever fast, and re-rate from a leveraged micro-cap to an omni-channel wellness consolidator.
Overview
FitLife Brands is in the midst of a scale and portfolio transformation from a niche sports nutrition operator into an omni-channel wellness consolidator. The defining event is the $42.5M Irwin Naturals acquisition (Aug 2025), which expanded product breadth (100+ SKUs, differentiated liquid soft-gels) and meaningfully increased wholesale/mass retail access while also introducing lower-margin mix and integration complexity. FY2025 revenue rose to $81.5M (+26% YoY) with a near-even channel split: ~51% online (primarily Amazon U.S.) and ~49% wholesale (GNC plus mass retailers like Walmart/Costco/CVS). Profitability optics weakened (gross margin down ~500 bps; net income down ~30%) due to mix and inventory step-up amortization, but adjusted EBITDA held roughly flat (~$14M) and Q4 showed strong post-deal scale. The opportunity is margin and cash-flow expansion via shifting Irwin toward Amazon/DTC and de-levering; the key risks are platform concentration, competitive intensity, and debt-funded balance sheet pressure.